Eupraxia Pharmaceuticals Inc banner

Eupraxia Pharmaceuticals Inc
TSX:EPRX

Watchlist Manager
Eupraxia Pharmaceuticals Inc Logo
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Watchlist
Price: 9.31 CAD -1.38% Market Closed
Market Cap: CA$483.6m

Intrinsic Value

The intrinsic value for Eupraxia Pharmaceuticals Inc (EPRX) under the Base Case is 1.55 CAD. Compared with the current market price of 9.31 CAD, the stock appears Overvalued by 83%.

EPRX Intrinsic Value
1.55 CAD
Overvaluation 83%
Intrinsic Value
Price CA$9.31
Base Case Scenario
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value CA$1.24
Get notified when the price drops into your buy zone
Current Price CA$9.31
Intrinsic Value CA$1.55
Margin of Safety 20% CA$1.24
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about EPRX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is EPRX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Eupraxia Pharmaceuticals Inc.

Explain Valuation
Alternatives to EPRX

Wall St
Price Targets

Dividends

Eupraxia Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one EPRX stock?

The intrinsic value for Eupraxia Pharmaceuticals Inc (EPRX) under the Base Case is 1.55 CAD.

Is EPRX stock undervalued or overvalued?

Compared with the current market price of 9.31 CAD, the stock appears Overvalued by 83%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett